switching between glp 1 agonists chart Schematic illustration of monoagonists, dual and triple Switching Between Glucagon-Like Peptide-1 Receptor
Description
Excretion: The major route of sitagliptin elimination is renal, with 79% of the administered dose excreted unchanged in the urine

A meta-analysis across randomized controlled trials found significant reductions in body weight averaging 12.4%, BMI by 4.0 kg/m2, and waist circumference by 8.0 cm

In obesity: 20% after 8 hr, n=10
Are you at least 18 years old

Room temperature storage degrades the peptide rapidly
